LifeTech Scientific Corporation
LFTSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $7,265,806 | $7,463,585 | $7,583,927 | $6,847,748 |
| - Cash | $782,609 | $665,755 | $832,577 | $979,312 |
| + Debt | $3,908 | $4,979 | $104,418 | $9,296 |
| Enterprise Value | $6,487,105 | $6,802,809 | $6,855,768 | $5,877,732 |
| Revenue | $676,707 | $650,868 | $652,831 | $627,670 |
| % Growth | 4% | -0.3% | 4% | – |
| Gross Profit | $497,755 | $466,051 | $515,384 | $490,832 |
| % Margin | 73.6% | 71.6% | 78.9% | 78.2% |
| EBITDA | $70,827 | $80,403 | $208,478 | $121,722 |
| % Margin | 10.5% | 12.4% | 31.9% | 19.4% |
| Net Income | $55,074 | $16,831 | $205,557 | $43,078 |
| % Margin | 8.1% | 2.6% | 31.5% | 6.9% |
| EPS Diluted | 0.013 | 0.004 | 0.046 | 0.01 |
| % Growth | 225.6% | -91.6% | 371.4% | – |
| Operating Cash Flow | $391,273 | $218,790 | $102,670 | $194,921 |
| Capital Expenditures | -$21,762 | -$101,832 | -$181,169 | -$101,273 |
| Free Cash Flow | $369,511 | $116,958 | -$78,499 | $93,648 |